Epsilon M&A Deal Report - Medi-Globe Technologies
Transaction Multiples for the Valuation of Private Companies
DCC / Medi-Globe Technologies
No EMAT :
109928
Announced Date :
08/09/2022
Type :
Exit ,Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
DCC
Target :
Medi-Globe Technologies
Country :
Germany
Sector of activity :
- Health Care Providers, Medical Equipment and Supplies > Health, Pharmaceuticals & Biotechnology > Medical Supplies
Business Description :
Founded in 1990, Medi-Globe Technologies develops, produces and markets a range of single- use products for minimally invasive diagnostic and therapeutic procedures in gastroenterology, urology and...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
|
|
||||
| Current |
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Medical Supplies » = 71
| Date | Acquirer | Target | Country | Multiples | See details |
| 30/08/2022 | Neurocrine Biosciences | Diurnal Group | Wales | *** | 109861 |
| 03/12/2021 | Recordati | Eusa Pharma (UK) | England | ** | 109851 |
Source: Epsilon Research / EMAT
